ArticleBreast cancer (Tokyo, Japan)2026

Clinical impact of ENIGMA-based variant reclassification on genotype-phenotype analyses in BRCA1- and BRCA2-associated hereditary breast and ovarian cancer.

Said Furkan Yildirim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.